Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH

55.32

-1.51(-2.66%)

Updated at November 07 03:00PM

Currency In CNY

Valuation

Market Cap5.28B
Enterprise Value4.42B
P/E Ratio42.25
PEG Ratio3.01
Price/Sales Ratio7.29
Price/Book Ratio3.47
Enterprise/Revenue6.78
Enterprise/EBITDA37.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.17
Operating Margin0.18

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue1.35B
Revenue/Share7.66
Gross Profit1B
EBITDA249.79M
Net Income238.23M
Diluted EPS1.36

Balance Sheet

Total Cash1.54B
Total Cash/Share8.84
Total Debt123.87M
Total Debt/Equity0.04
Current Ratio3.46
Book Value Per Share15.95

Price History

52-Week Change48.11
52-Week High73.66
52-Week Low28.85
Moving Average 50 Days56.41
Moving Average 200 Days44.51

Statistics

Average Volume3.63M
Shares Outstanding176M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.43
Trailing Annual Dividend Yield0.78
Payout Ratio0.47
Last Split Factor147:100
Last Split DateJuly 01, 2024